Why is Sandu Pharma. falling/rising?

As of 01-Sep, Sandu Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 47.16, which reflects a decrease of Rs 1.83 or 3.74%. The stock has underperformed its sector by 6.26% today and has touched an intraday low of Rs 47.16. Over the past week, the stock has decreased by 4.17%, and its performance over the last year shows a significant decline of 21.14%. Despite a 5.9% increase in profits over the past year, the stock's return on equity (ROE) is low at 3.7%, indicating weak long-term fundamental strength. Additionally, the stock is trading below its moving averages across multiple timeframes, which suggests a bearish trend.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as the Sensex has only declined by 1.56% over the past week. This consistent underperformance against the benchmark over the last three years, coupled with a significant drop in investor participation—evidenced by an 81.36% fall in delivery volume—highlights a lack of confidence among investors. Furthermore, the company's weak ability to service its debt, indicated by a poor EBIT to Interest ratio, adds to the negative sentiment surrounding the stock, contributing to its ongoing decline.